Peritoneal Dialysis Aggravates and Accelerates Atherosclerosis in Uremic ApoE −/− Mice

Background Atherosclerosis is highly prevalent in people with chronic kidney disease (CKD), including those receiving peritoneal dialysis (PD). Although it is lifesaving, PD induces profound systemic inflammation, which may aggravate atherosclerosis. Therefore, the hypothesis is that this PD‐induced...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Heart Association Vol. 13; no. 14; p. e034066
Main Authors Kane, Jamie, Vos, Winnie G., Bosmans, Laura A., van Os, Bram W., den Toom, Myrthe, Hoeksema‐Hackmann, Sanne, Moen‐de Wit, Denise, Gijbels, Marion J., Beckers, Linda, Grefhorst, Aldo, Levels, Johannes H. M., Jakulj, Lily, Vervloet, Marc G., Lutgens, Esther, Eringa, Etto C.
Format Journal Article
LanguageEnglish
Published Hoboken John Wiley and Sons Inc 16.07.2024
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Atherosclerosis is highly prevalent in people with chronic kidney disease (CKD), including those receiving peritoneal dialysis (PD). Although it is lifesaving, PD induces profound systemic inflammation, which may aggravate atherosclerosis. Therefore, the hypothesis is that this PD‐induced inflammation aggravates atherosclerosis via immune cell activation. Methods and Results ApoE −/− mice were subjected to a 5/6 nephrectomy to induce CKD. Three weeks later, mice were fed a high‐cholesterol diet. Half of the nephrectomized mice then received daily peritoneal infusions of 3.86% Physioneal for 67 further days (CKD+PD) until the end of the experiment, and were compared with mice without CKD. Sham operated and PD‐only mice were additional controls. CKD+PD mice displayed more severe atherosclerotic disease than control mice. Plaque area increased, and plaques were more advanced with a vulnerable phenotype typified by decreased collagen content and decreased fibrous cap thickness. Increased CD3 + T‐cell numbers were present in plaques and perivascular adipose tissue of CKD and CKD+PD mice. Plaques of CKD+PD mice contained more iNOS + immune cells. Spleens of CKD+PD mice showed more CD4 + central memory, terminally differentiated type 1 T‐helper (Th1), Th17, and CX3C motif chemokine receptor 1 + (CX3CR1) CD4 + T‐cells with less regulatory and effector T‐cells. Conclusions PD‐fluid exposure in uremic mice potentiates systemic and vascular T‐cell‐driven inflammation and aggravates atherosclerosis. PD polarized CD4 + T‐cells toward an inflammatory Th1/Th17 phenotype, and increased CX3CR1 + CD4 + T‐cells, which are associated with vascular homing in CKD‐associated atherosclerosis. Targeting CD4 + T‐cell activation and CX3CR1 + polarization has the potential to attenuate atherosclerosis in PD patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This manuscript was sent to Julie K. Freed, MD, PhD, Associate Editor, for review by expert referees, editorial decision, and final disposition.
E. Lutgens and E. C. Eringa contributed equally.
Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.123.034066
For Sources of Funding and Disclosures, see page 13.
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.123.034066